FDA-Drug2026-04-22Class IIPROCESSING DEFECT

Taro Pharmaceuticals fluocinonide cream recalled for failed viscosity specifications

OTHERNationwide distributionDrugs

What this means

Taro Pharmaceuticals is recalling one lot of fluocinonide 0.05% cream due to viscosity testing that showed the cream is thicker than the approved specification. This may affect how the medication spreads and absorbs. No injuries have been reported.

  • Check if you have lot #AD76250 with expiration date 6/30/2026 (NDC 51672-1386-3)
  • If you have this lot, stop using it and contact your pharmacy or doctor
  • Your pharmacist can provide a replacement or alternative
The agency's original wording
Hazard

Failed Viscosity Specifications: Out of Specification results, above the specification limit, in viscosity, noted during stability testing.

Intended for
Adults
Illnesses reported
None reported
Sold states
Nationwide in the USA.
Affected count
2,640 60g tubes
Manufactured in
2 Independence Way, N/A, Princeton, NJ, United States
Products
Fluocinonide, USP, 0.05% Cream, 60g tube, Rx only, Mfd by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada L6T 1C1, Dist. by: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, NDC 51672-1386-3.

Official notice

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0477-2026

More Sun Pharmaceutical recalls

Want us to check the next one for you?

We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.

Free · One email a week · Unsubscribe anytime